Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Defective regulation of adipose tissue autophagy in obesity.

Nuñez CE, Rodrigues VS, Gomes FS, Moura RF, Victorio SC, Bombassaro B, Chaim EA, Pareja JC, Geloneze B, Velloso LA, Araujo EP.

Int J Obes (Lond). 2013 Nov;37(11):1473-80. doi: 10.1038/ijo.2013.27. Epub 2013 Mar 12.

PMID:
23478428
2.

Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance.

Samaras K, Viardot A, Lee PN, Jenkins A, Botelho NK, Bakopanos A, Lord RV, Hayward CS.

Diab Vasc Dis Res. 2013 Jan;10(1):40-8. doi: 10.1177/1479164112443375. Epub 2012 Apr 25.

PMID:
22535587
3.

Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression.

Jansen HJ, van Essen P, Koenen T, Joosten LA, Netea MG, Tack CJ, Stienstra R.

Endocrinology. 2012 Dec;153(12):5866-74. doi: 10.1210/en.2012-1625. Epub 2012 Nov 1.

PMID:
23117929
4.

Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.

Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, Jardel C, Donner M, Meyer L, Moulin P, Hainque B, Riou JP, Laville M, Koivisto VA, Vidal H.

Eur J Clin Invest. 2000 Apr;30(4):302-10.

PMID:
10759878
5.

Autophagy in adipose tissue of patients with obesity and type 2 diabetes.

Kosacka J, Kern M, Klöting N, Paeschke S, Rudich A, Haim Y, Gericke M, Serke H, Stumvoll M, Bechmann I, Nowicki M, Blüher M.

Mol Cell Endocrinol. 2015 Jul 5;409:21-32. doi: 10.1016/j.mce.2015.03.015. Epub 2015 Mar 26.

PMID:
25818883
6.

Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B.

J Clin Endocrinol Metab. 2000 Sep;85(9):3338-42.

PMID:
10999830
7.

IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.

Fabrizi M, Marchetti V, Mavilio M, Marino A, Casagrande V, Cavalera M, Moreno-Navarrete JM, Mezza T, Sorice GP, Fiorentino L, Menghini R, Lauro R, Monteleone G, Giaccari A, Fernandez Real JM, Federici M.

Diabetes. 2014 Jun;63(6):2086-96. doi: 10.2337/db13-0939. Epub 2014 Jan 15.

8.

Transcriptomics applied to obesity and caloric restriction.

Viguerie N, Poitou C, Cancello R, Stich V, Clément K, Langin D.

Biochimie. 2005 Jan;87(1):117-23. Review.

PMID:
15733746
9.

Adipose tissue CIDEA is associated, independently of weight variation, to change in insulin resistance during a longitudinal weight control dietary program in obese individuals.

Montastier E, Déjean S, Le Gall C, Saris WH, Langin D, Viguerie N.

PLoS One. 2014 Jul 1;9(7):e98707. doi: 10.1371/journal.pone.0098707. eCollection 2014.

10.

Differential adipose tissue inflammatory state in obese nondiabetic Zucker fatty rats compared to obese diabetic zucker diabetic fatty rats.

Miranville A, Herling AW, Biemer-Daub G, Voss MD.

Horm Metab Res. 2012 Apr;44(4):273-8. doi: 10.1055/s-0032-1304581. Epub 2012 Mar 7.

PMID:
22399237
11.

Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.

Stolic M, Russell A, Hutley L, Fielding G, Hay J, MacDonald G, Whitehead J, Prins J.

Int J Obes Relat Metab Disord. 2002 Jan;26(1):17-23.

PMID:
11791142
12.

Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.

Fabbrini E, Cella M, McCartney SA, Fuchs A, Abumrad NA, Pietka TA, Chen Z, Finck BN, Han DH, Magkos F, Conte C, Bradley D, Fraterrigo G, Eagon JC, Patterson BW, Colonna M, Klein S.

Gastroenterology. 2013 Aug;145(2):366-74.e1-3. doi: 10.1053/j.gastro.2013.04.010. Epub 2013 Apr 15.

13.

Eotaxin and obesity.

Vasudevan AR, Wu H, Xydakis AM, Jones PH, Smith EO, Sweeney JF, Corry DB, Ballantyne CM.

J Clin Endocrinol Metab. 2006 Jan;91(1):256-61. Epub 2005 Nov 1.

PMID:
16263831
15.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
16.

Pro-inflammatory wnt5a and anti-inflammatory sFRP5 are differentially regulated by nutritional factors in obese human subjects.

Schulte DM, Müller N, Neumann K, Oberhäuser F, Faust M, Güdelhöfer H, Brandt B, Krone W, Laudes M.

PLoS One. 2012;7(2):e32437. doi: 10.1371/journal.pone.0032437. Epub 2012 Feb 23.

17.

Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.

Van der Schueren B, Vangoitsenhoven R, Geeraert B, De Keyzer D, Hulsmans M, Lannoo M, Huber HJ, Mathieu C, Holvoet P.

Int J Obes (Lond). 2015 Aug;39(8):1254-63. doi: 10.1038/ijo.2015.58. Epub 2015 Apr 14.

PMID:
25869607
18.

Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects.

Clément K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D.

FASEB J. 2004 Nov;18(14):1657-69.

19.

Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation.

Naour N, Rouault C, Fellahi S, Lavoie ME, Poitou C, Keophiphath M, Eberlé D, Shoelson S, Rizkalla S, Bastard JP, Rabasa-Lhoret R, Clément K, Guerre-Millo M.

J Clin Endocrinol Metab. 2010 Apr;95(4):1861-8. doi: 10.1210/jc.2009-1894. Epub 2010 Feb 17.

PMID:
20164293
20.

Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children.

Roth CL, Kratz M, Ralston MM, Reinehr T.

Metabolism. 2011 Apr;60(4):445-52. doi: 10.1016/j.metabol.2010.03.023. Epub 2010 May 24.

PMID:
20494373
Items per page

Supplemental Content

Write to the Help Desk